Insception Cord Blood Program Featured in Praxair News
Praxair, a company which supplies gasses and coatings, has featured Insception in its latest newsletter, profiling our use of liquid nitrogen to freeze cord blood stem cells.
The stem cells which are derived from a baby’s umbilical cord at birth must be cryopreserved after being collected. This is an important step in the successful storage of umbilical cord blood.
Praxair provides Insception’s liquid nitrogen supply and its freezing system, helping our company to provide a quality service for the families who choose to bank with Insception. The company also helps to advise Insception about ways to manage our growing collection of cord blood stem cells.
“Insception is anticipating a future where the lives of more people are improved through cord blood transfusions and related stem cell therapies,” the newsletter states. “We are proud to be helping them achieve that goal”.
Insception’s partnership with Praxair has been a successful and mutually-beneficial one. We look forward to future endeavors with the company.
To read the full article, click here: http://www.insception.com/sites/default/files/PraxairNews_November_StemC...




